Your Article Summary
Prostate cancer: Hormonal therapy for life
NCP Urology, 06/09/09
Senior K - The results are provocative, but this secondary analysis is a hypothesis-generating exercise; conclusively defining the optimal duration of hormonal therapy in the adjuvant setting for patients with high-risk disease would require a prospective phase III study.
Related Articles
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 72%
Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection
The Journal of Urology, 11/13/09
Relevance Score: 71%
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 71%
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men
The Prostate, 11/02/09
Relevance Score: 71%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 71%
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
Lower urinary tract symptoms, obesity and the metabolic syndrome
Current Opinion in Urology, 12/09/09
LH, Non-SHBG Testosterone and Estradiol Levels during Testosterone Replacement of Hypogonadal Men: Further Evidence that Steroid Negative Feedback Increases as Men Grow Older
Journal of Andrology, 12/08/09
Oestrogenic mycotoxin exposures and precocious pubertal development
International Journal of Andrology, 12/03/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutation analysis of the MSMB gene in familial prostate cancer
British Journal of Cancer, 12/10/09
[F18]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study
European Journal of Cancer, 12/10/09
Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
Cancer, 12/10/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutation analysis of the MSMB gene in familial prostate cancer
British Journal of Cancer, 12/10/09
[F18]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study
European Journal of Cancer, 12/10/09
Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
Cancer, 12/10/09

See Latest Articles